Dieter Gericke

Partner

Dieter Gericke heads the Corporate | M&A practice team. He focuses on M&A (including public takeovers and defense), equity capital markets (incl. IPOs), private equity and financing. He advises in matters of corporate law and governance, as well as securities regulations. He is an Authorized Issuers' Representative at the SIX Swiss Exchange.

Dieter Gericke's assignments included advising China National Chemical Corporation (ChemChina) in the public takeover of Syngenta, Therachon in the sale to Pfizer, Meyer Burger in the proxy fight against activists, Bregal in the acquisition of Kunststoff Schwanden, Bühler in the acquisition of Haas Group, Givaudan in the acquisition of Activ International, Mubadala in the sale of SR Technics to HNA, Infront Sports & Media Group in the sale to Dalian Wanda Group, BB Biotech in the defense against Bank Vontobel's unsolicited takeover approach, Nestlé in the sale of Alcon to Novartis, Kering in the acquisition of Ulysse Nardin or SCOR in the unsolicited takeover of Converium. IPOs included Zur Rose Group, AC Immune, Endosense, ADC Therapeutics, Kuros Biosurgery, Molecular Partners, Gategroup, Santhera, BioXell or tamedia. He has long-standing experience in assisting boards of directors and managements of public and private companies in corporate governance matters and specific challenges like shareholder activism and -claims, proxy-fights, regulatory matters, reorganizations and directors' & officers' liability. Dieter Gericke has a particularly strong foothold in the life sciences, engineering and technology as well as insurance industries.


Dieter Gericke has spoken on various panels of the International Bar Association, where he is a member of the Corporate and M&A Committee of the Securities Law Committee. He has chaired or been a speaker at numerous conferences with recent speaking topics including shareholder activism, influence of proxy advisors, tactics and timing in negotiations, takeover laws, trade sale transactions or joint ventures.


In his areas of practice Dieter Gericke authored various publications and legal opinions, including on mergers & acquisitions, securities laws, directors' and officers' duties and liability and say-on-pay regulations. Dieter Gericke joined Homburger as an associate in 2000 and has been partner since 2004 and head of the Corporate M&A practice team since 2014. Since 2010, he also heads the Homburger China Group. He studied law at the University of Zurich, where he graduated and accomplished his doctorate, both summa cum laude. In 1999, he graduated from Harvard Law School with an LL.M. In addition, Dieter Gericke studied one semester at Université de Paris II (Assas).


Dieter Gericke has been a member of the boards of directors of Syngenta AG, a leading agriculture company, and, since many years, of Gericke Group, which produces powder processing equipment and systems for food, pharma and chemical industries. In addition he is serving in honorary capacity as a member of the board of supervisors of Theater an der Winkelwiese, Zurich and of the Harvard Club of Switzerland.

Career
  • 2014 Head of the Corporate | M&A practice team
  • 2010 Head of the China Focus Group
  • 2004 Partner at Homburger
  • 2000 Associate at Homburger
  • 1999 Foreign Associate at Wilmer Hale, Boston
  • 1999 Harvard Law School (LL.M.)
  • 1996 Associate at a Zurich law firm
  • 1996 Lecturer in Corporate Law at the University of Zurich
  • 1996 University of Zurich (Dr. iur., summa cum laude)
  • 1994 Research assistant at the University of Zurich
  • 1994 Bar admission
  • 1991 Law clerk at the District Court of Meilen-Zurich
  • 1991 University of Zurich (lic. iur., summa cum laude)
Languages
German, English, French
Bar registration
At all Swiss courts
Address
Prime Tower
Hardstrasse 201
CH-8005 Zurich
P+41 43 222 16 59 | 15 18
M+41 79 253 55 26
F+41 43 222 15 00

Dieter Gericke heads the Corporate | M&A practice team. He focuses on public and private mergers & acquisitions, private equity, capital markets (incl. IPOs) and finance. He advises in matters of corporate law and securities regulations.

Career
  • 2014 Head of the Corporate | M&A practice team
  • 2010 Head of the China Focus Group
  • 2004 Partner at Homburger
  • 1999 Foreign Associate at Wilmer Hale, Boston
  • 1999 Harvard Law School (LL.M.)
  • 1996 University of Zurich (Dr. iur.)
  • 1996 Lecturer in Corporate Law at the University of Zurich
  • 1994 Bar admission
  • 1991 Law clerk at the District Court of Meilen-Zurich
  • 1991 University of Zurich (lic. iur.)
Languages
German, English, French
Bar registration
At all Swiss courts
P+41 43 222 16 59 | 15 18
M+41 79 253 55 26
F+41 43 222 15 00
Address
Prime Tower
Hardstrasse 201
CH-8005 Zurich